Welcome back to another edition of Endpoints Weekly. Two of the year’s major oncology conferences are coming up soon: AACR starting April 17, and ASCO

Following a judge’s ruling that suspended most of the Trump administration’s appointments to the CDC’s vaccine advisory panel, a newly published charter for the panel

The FDA has once again rejected Replimune’s oncolytic virus therapy to treat advanced melanoma. The Massachusetts-based drugmaker had been pushing for a reconsideration by the

Five people with beta thalassemia who had their blood stem cells genetically altered no longer require regular blood transfusions to stay healthy. Their Chinese-made treatment

New China-US biotech gets $54M: Vivatides Therapeutics raised the Series A for its preclinical-stage R&D in siRNA and antisense oligonucleotides aimed at reaching tissues beyond